Overall, our findings show that increased O-GlcNAcylation of eNOS impairs the activity of this enzyme and the subsequent NO production in the PVAT and support the concept that PVAT O-GlcNAcylation may be a significant contributing factor to vascular dysfunction in metabolic syndrome. Here, NOS3 is linked to metabolic syndrome.